Overall Status

Completed (180)

Not yet recruiting (13)

Unknown status (10)

Recruiting (9)

Terminated (8)

Withdrawn (5)

Active, not recruiting (2)

Enrolling by invitation (1)

Phase

phase 4 (60)

phase 3 (51)

phase 1 (35)

phase 2 (34)

n/a (27)

phase 2/phase 3 (5)

early phase 1 (2)

phase 1/phase 2 (2)

Study Documents

Intervention Type

drug (217)

other (18)

dietary supplement (7)

behavioral (6)

procedure (5)

device (3)

biological (2)

combination product (1)

Funder Type

Industry (145)

Other (80)

NIH (2)

U.S. Fed (1)

Study Type

Interventional (216)

Observational (12)

Tolterodine Tartrate

Showing 226 - 228 of 228

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Overactive Bladder Trial in Haifa (DETRUSITOL)

Unknown status

Overactive Bladder

DETRUSITOL

Haifa, Israel

Rambam Healthcare Center

Feb 19, 2007

Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter

Completed

Healthy

Brimonidine tartrate ophthalmic solution 0.15% (Alphagan P)

Washington, District of Columbia

Walter Reed Army Medical Center

Dec 19, 2006

Ocular Physiology, Regional Blood Flow Trial in Vienna (Clonidin, Brimonidine)

Completed

Ocular Physiology
Regional Blood Flow

Vienna, Austria

Department of Clinical Pharmacology

Feb 9, 2007